Publicaciones en colaboración con investigadores/as de Centro de Investigación Príncipe Felipe (13)

2020

  1. Dapagliflozin does not modulate atherosclerosis in mice with insulin resistance

    International Journal of Molecular Sciences, Vol. 21, Núm. 23, pp. 1-18

2019

  1. Changes in CDKN2A/2B expression associate with T-cell phenotype modulation in atherosclerosis and type 2 diabetes mellitus

    Translational Research, Vol. 203, pp. 31-48

  2. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis

    Diabetologia, Vol. 62, Núm. 11, pp. 2143-2157

  3. Type 1 diabetic mellitus patients with increased atherosclerosis risk display decreased CDKN2A/2B/2BAS gene expression in leukocytes

    Journal of Translational Medicine, Vol. 17, Núm. 1

2016

  1. Hepatic lipase inactivation decreases atherosclerosis in insulin resistance by reducing LIGHT/lymphotoxin β-receptor pathway

    Thrombosis and Haemostasis, Vol. 116, Núm. 2, pp. 379-393

2015

  1. Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis

    Journal of Endocrinology, Vol. 227, Núm. 3, pp. 179-191

  2. Ink4/Arf locus restores glucose tolerance and insulin sensitivity by reducing hepatic steatosis and inflammation in mice with impaired IRS2-dependent signalling

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1852, Núm. 9, pp. 1729-1742

2014

  1. Insulin resistance aggravates atherosclerosis by reducing vascular smoothmuscle cell survival and increasing CX3CL1/CX3CR1 axis

    Cardiovascular Research, Vol. 103, Núm. 2, pp. 324-336

2013

  1. Increased dosage of Ink4/Arf protects against glucose intolerance and insulin resistance associated with aging

    Aging Cell, Vol. 12, Núm. 1, pp. 102-111

2011

  1. Deficient p27 phosphorylation at serine 10 increases macrophage foam cell formation and aggravates atherosclerosis through a proliferation-independent mechanism

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 31, Núm. 11, pp. 2455-2463

2008

  1. Molecular mechanisms of atherosclerosis in metabolic syndrome: Role of reduced IRS2-dependent signaling

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 28, Núm. 12, pp. 2187-2194

2007

  1. Murine models to investigate the influence of diabetic metabolism on the development of atherosclerosis and restenosis

    Frontiers in Bioscience, Vol. 12, Núm. 12, pp. 4439-4455

  2. Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice

    Frontiers in Bioscience, Vol. 12, Núm. 6, pp. 2291-2298